ZS Pharma, Inc. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
ZS Pharma, Inc. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $172.96 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2015-11-09
- ZS Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-09-30 was $1.01M, a 89.31% decline year-over-year.
- ZS Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-06-30 was -$2.44M, a 102.11% decline year-over-year.
- ZS Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-03-31 was $174.40M, a 605.61% increase year-over-year.
- ZS Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2014-12-31 was $28.00K, a 33.33% decline year-over-year.
- ZS Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $150.14M, a 896.36% increase from fiscal 2013.
- ZS Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $15.07M, a 47.37% decline from fiscal 2012.
- ZS Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2012 was $28.63M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2015-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$1.43M derived: sum of 2 quarters · filed 2015-11-09 | $172.96M 10-Q · filed 2015-11-09 | $172.99M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | -$2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $171.96M 10-Q · filed 2015-08-06 | $171.98M derived: sum of 3 quarters · filed 2015-08-06 | $181.42M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | $174.40M 10-Q · filed 2015-05-11 | $174.43M derived: sum of 2 quarters · filed 2015-05-11 | $183.86M derived: sum of 3 quarters · filed 2015-11-09 | $299.82M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $9.46M derived: sum of 2 quarters · filed 2015-11-09 | $125.42M derived: sum of 3 quarters · filed 2015-11-09 | $150.14M 10-K · filed 2015-03-13 |
| 2014-09-30 | $9.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $125.40M derived: sum of 2 quarters · filed 2015-11-09 | $150.11M 10-Q · filed 2015-11-09 | $150.16M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $115.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $140.68M 10-Q · filed 2015-08-06 | $140.72M derived: sum of 3 quarters · filed 2015-08-06 | $155.82M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $24.72M 10-Q · filed 2015-05-11 | $24.76M derived: sum of 2 quarters · filed 2015-05-11 | $39.85M derived: sum of 3 quarters · filed 2015-05-11 | |
| 2013-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $15.14M derived: sum of 2 quarters · filed 2015-03-13 | $15.07M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $15.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $15.03M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | -$70.00K 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $28.63M 10-K · filed 2015-03-13 |